Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinal Pigment Epithelium | 8 | 2016 | 302 | 1.600 |
Why?
|
Blood-Retinal Barrier | 4 | 2016 | 62 | 1.170 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2023 | 19 | 0.900 |
Why?
|
Vascular Endothelial Growth Factor A | 7 | 2018 | 3508 | 0.660 |
Why?
|
Retinal Hemorrhage | 1 | 2018 | 96 | 0.630 |
Why?
|
Polyps | 1 | 2018 | 189 | 0.590 |
Why?
|
Choroid | 1 | 2018 | 322 | 0.570 |
Why?
|
Choroidal Neovascularization | 2 | 2018 | 343 | 0.540 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 412 | 0.540 |
Why?
|
Ophthalmology | 1 | 2021 | 508 | 0.500 |
Why?
|
Macular Edema | 2 | 2016 | 359 | 0.490 |
Why?
|
Retinal Diseases | 1 | 2020 | 683 | 0.460 |
Why?
|
Natriuretic Peptide, C-Type | 1 | 2012 | 23 | 0.440 |
Why?
|
Papilledema | 1 | 2014 | 118 | 0.440 |
Why?
|
Retina | 3 | 2020 | 2616 | 0.440 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 546 | 0.420 |
Why?
|
Tomography, Optical Coherence | 8 | 2022 | 2657 | 0.380 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1339 | 0.360 |
Why?
|
Retinal Perforations | 2 | 2022 | 131 | 0.350 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2214 | 0.310 |
Why?
|
Fluorescein Angiography | 4 | 2022 | 940 | 0.270 |
Why?
|
Electroretinography | 5 | 2020 | 509 | 0.260 |
Why?
|
Retinal Degeneration | 3 | 2014 | 415 | 0.260 |
Why?
|
Fundus Oculi | 4 | 2022 | 473 | 0.220 |
Why?
|
Iridocyclitis | 1 | 2021 | 11 | 0.200 |
Why?
|
Vision, Monocular | 1 | 2022 | 78 | 0.200 |
Why?
|
Uveitis, Intermediate | 1 | 2021 | 17 | 0.200 |
Why?
|
Serum Albumin | 2 | 2015 | 676 | 0.190 |
Why?
|
Vision, Binocular | 1 | 2022 | 213 | 0.190 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2014 | 789 | 0.180 |
Why?
|
Intravitreal Injections | 2 | 2018 | 344 | 0.180 |
Why?
|
Endotamponade | 1 | 2019 | 35 | 0.170 |
Why?
|
Epiretinal Membrane | 1 | 2019 | 68 | 0.160 |
Why?
|
Eye | 1 | 2023 | 729 | 0.160 |
Why?
|
Rabbits | 2 | 2015 | 4894 | 0.160 |
Why?
|
Uveitis | 1 | 2021 | 375 | 0.150 |
Why?
|
Visual Field Tests | 1 | 2020 | 383 | 0.150 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2020 | 245 | 0.150 |
Why?
|
Reperfusion Injury | 2 | 2014 | 1026 | 0.150 |
Why?
|
Indocyanine Green | 1 | 2018 | 239 | 0.150 |
Why?
|
Retinoids | 2 | 2014 | 101 | 0.140 |
Why?
|
Coloring Agents | 1 | 2018 | 566 | 0.140 |
Why?
|
Vitrectomy | 1 | 2019 | 365 | 0.140 |
Why?
|
Immunoblotting | 2 | 2016 | 1682 | 0.130 |
Why?
|
Lipofuscin | 1 | 2013 | 44 | 0.120 |
Why?
|
Histone Deacetylase 2 | 1 | 2013 | 74 | 0.110 |
Why?
|
Ocular Hypertension | 1 | 2014 | 198 | 0.110 |
Why?
|
Visual Acuity | 2 | 2019 | 2530 | 0.110 |
Why?
|
Visual Fields | 1 | 2020 | 1047 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2015 | 18029 | 0.100 |
Why?
|
Caspase 3 | 1 | 2014 | 758 | 0.100 |
Why?
|
Complement Membrane Attack Complex | 1 | 2012 | 112 | 0.100 |
Why?
|
Retinal Ganglion Cells | 2 | 2014 | 770 | 0.100 |
Why?
|
Cyclic GMP | 1 | 2012 | 409 | 0.100 |
Why?
|
Atrial Natriuretic Factor | 1 | 2012 | 393 | 0.100 |
Why?
|
Blotting, Western | 3 | 2014 | 5179 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 2 | 2018 | 2038 | 0.100 |
Why?
|
Rats, Inbred BN | 3 | 2016 | 235 | 0.100 |
Why?
|
Cadaver | 1 | 2015 | 1337 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2016 | 1116 | 0.090 |
Why?
|
Lysine | 1 | 2014 | 1007 | 0.090 |
Why?
|
Histone Deacetylases | 1 | 2014 | 728 | 0.090 |
Why?
|
Intraocular Pressure | 1 | 2014 | 1270 | 0.080 |
Why?
|
Cyclic AMP | 1 | 2012 | 1472 | 0.080 |
Why?
|
Biological Assay | 1 | 2011 | 652 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2505 | 0.080 |
Why?
|
Macular Degeneration | 2 | 2014 | 980 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3143 | 0.080 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11366 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1373 | 0.070 |
Why?
|
Diabetic Retinopathy | 1 | 2016 | 1210 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4262 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3870 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2012 | 1573 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2599 | 0.060 |
Why?
|
Humans | 13 | 2023 | 744343 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2016 | 19229 | 0.050 |
Why?
|
Valproic Acid | 2 | 2014 | 445 | 0.050 |
Why?
|
Acetylation | 2 | 2014 | 1085 | 0.050 |
Why?
|
Cell Line | 2 | 2012 | 15997 | 0.050 |
Why?
|
Hydroxamic Acids | 2 | 2014 | 494 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13881 | 0.050 |
Why?
|
Animals | 7 | 2016 | 168757 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2011 | 3690 | 0.040 |
Why?
|
Middle Aged | 4 | 2023 | 213383 | 0.040 |
Why?
|
Male | 6 | 2023 | 350118 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8664 | 0.030 |
Why?
|
Retinal Neurons | 1 | 2014 | 66 | 0.030 |
Why?
|
Acetyltransferases | 1 | 2014 | 234 | 0.030 |
Why?
|
Pyridinium Compounds | 1 | 2013 | 84 | 0.030 |
Why?
|
Rhodopsin | 1 | 2014 | 203 | 0.030 |
Why?
|
Signal Transduction | 2 | 2014 | 23403 | 0.030 |
Why?
|
Retinaldehyde | 1 | 2011 | 25 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2014 | 3086 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 503 | 0.020 |
Why?
|
Retinal Vessels | 1 | 2016 | 772 | 0.020 |
Why?
|
Vision, Ocular | 1 | 2014 | 464 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2014 | 2645 | 0.020 |
Why?
|
Chronic Disease | 2 | 2016 | 9146 | 0.020 |
Why?
|
Serpins | 1 | 2011 | 247 | 0.020 |
Why?
|
Tight Junctions | 1 | 2011 | 311 | 0.020 |
Why?
|
Rats | 2 | 2016 | 24260 | 0.020 |
Why?
|
Tretinoin | 1 | 2011 | 517 | 0.020 |
Why?
|
Nerve Growth Factors | 1 | 2011 | 574 | 0.020 |
Why?
|
Complement System Proteins | 1 | 2012 | 795 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2011 | 1137 | 0.020 |
Why?
|
Eye Proteins | 1 | 2011 | 646 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2014 | 941 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 21827 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.020 |
Why?
|
Fetus | 1 | 2012 | 1880 | 0.010 |
Why?
|
Viral Proteins | 1 | 2011 | 1900 | 0.010 |
Why?
|
Cell Survival | 1 | 2014 | 5882 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2077 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2014 | 3798 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5319 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57776 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9734 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
Female | 4 | 2022 | 380194 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 85781 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14557 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81183 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12072 | 0.010 |
Why?
|
Aged | 2 | 2019 | 163280 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 25625 | 0.010 |
Why?
|
Adult | 2 | 2019 | 214055 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 41006 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 77449 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13695 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 56430 | 0.000 |
Why?
|
Child | 1 | 2013 | 77709 | 0.000 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_